Rx Roundup: Quiz of the Week — June 28, 2024

In an abstract presented at the American Diabetes Association 85th Scientific Sessions, researchers tested the effectiveness of an AI-driven program for improving glycemic control.

During Viral Hepatitis Awareness Month, Jeff Goad, PharmD, MPH, joined Over the Counter to discuss hepatitis vaccines and the common trends pharmacists in this space should keep in mind.

An ambulatory care pharmacist program in Washington State dramatically improved diabetes management by reducing A1c levels, increasing medication adherence, and providing comprehensive patient education.

In the first episode of the podcast, Jennifer Goldman and Hailey Choi discuss the latest FDA updates around compounded weight loss medications, clinical concerns and how pharmacists can protect their patients.

Results from the CATALYST trial showed patients who received mifepristone had a mean HbA1c reduction of 1.47%,

From 2019 to 2024, GLP-1 prescriptions among pediatric patients with type 2 diabetes increased from 12.3% to 60.9%.